A detailed history of Baillie Gifford & CO transactions in Penumbra Inc stock. As of the latest transaction made, Baillie Gifford & CO holds 591,846 shares of PEN stock, worth $142 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
591,846
Previous 614,863 3.74%
Holding current value
$142 Million
Previous $111 Million 3.85%
% of portfolio
0.09%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$163.64 - $210.12 $3.77 Million - $4.84 Million
-23,017 Reduced 3.74%
591,846 $115 Million
Q2 2024

Jul 25, 2024

SELL
$172.27 - $223.95 $3.35 Million - $4.36 Million
-19,456 Reduced 3.07%
614,863 $111 Million
Q1 2024

May 01, 2024

SELL
$220.09 - $273.15 $3 Million - $3.72 Million
-13,634 Reduced 2.1%
634,319 $142 Million
Q4 2023

Jan 26, 2024

SELL
$181.44 - $260.22 $5.75 Million - $8.24 Million
-31,674 Reduced 4.66%
647,953 $163 Million
Q3 2023

Nov 13, 2023

SELL
$240.69 - $338.77 $4.34 Million - $6.1 Million
-18,019 Reduced 2.58%
679,627 $164 Million
Q2 2023

Jul 28, 2023

SELL
$271.54 - $344.06 $8.34 Million - $10.6 Million
-30,710 Reduced 4.22%
697,646 $240 Million
Q1 2023

May 03, 2023

SELL
$220.43 - $278.69 $118 Million - $149 Million
-533,452 Reduced 42.28%
728,356 $203 Million
Q4 2022

Jan 24, 2023

BUY
$151.88 - $228.5 $25,819 - $38,845
170 Added 0.01%
1,261,808 $281 Million
Q3 2022

Oct 27, 2022

SELL
$120.36 - $205.88 $1.4 Million - $2.4 Million
-11,636 Reduced 0.91%
1,261,638 $239 Million
Q2 2022

Aug 08, 2022

SELL
$116.09 - $227.33 $2.98 Million - $5.84 Million
-25,683 Reduced 1.98%
1,273,274 $159 Million
Q1 2022

May 05, 2022

SELL
$187.51 - $283.98 $4.45 Million - $6.74 Million
-23,720 Reduced 1.79%
1,298,957 $289 Million
Q4 2021

Jan 20, 2022

SELL
$238.08 - $288.0 $254,031 - $307,296
-1,067 Reduced 0.08%
1,322,677 $380 Million
Q3 2021

Oct 19, 2021

SELL
$250.72 - $291.24 $3.86 Million - $4.49 Million
-15,402 Reduced 1.15%
1,323,744 $353 Million
Q2 2021

Aug 02, 2021

BUY
$235.0 - $310.7 $13.1 Million - $17.3 Million
55,761 Added 4.34%
1,339,146 $367 Million
Q1 2021

May 06, 2021

BUY
$175.6 - $291.43 $22.2 Million - $36.9 Million
126,619 Added 10.95%
1,283,385 $347 Million
Q4 2020

Feb 10, 2021

BUY
$174.98 - $272.83 $10.9 Million - $16.9 Million
62,089 Added 5.67%
1,156,766 $202 Million
Q3 2020

Nov 12, 2020

BUY
$185.27 - $238.73 $11.9 Million - $15.3 Million
64,284 Added 6.24%
1,094,677 $213 Million
Q2 2020

Aug 12, 2020

BUY
$153.32 - $191.72 $11 Million - $13.7 Million
71,673 Added 7.48%
1,030,393 $184 Million
Q1 2020

May 08, 2020

SELL
$124.34 - $193.76 $1.79 Million - $2.79 Million
-14,406 Reduced 1.48%
958,720 $155 Million
Q4 2019

Feb 10, 2020

SELL
$134.81 - $177.8 $16 Million - $21.2 Million
-118,989 Reduced 10.9%
973,126 $160 Million
Q3 2019

Nov 07, 2019

SELL
$131.82 - $183.4 $486,415 - $676,746
-3,690 Reduced 0.34%
1,092,115 $147 Million
Q2 2019

Aug 08, 2019

BUY
$124.65 - $167.39 $21.3 Million - $28.6 Million
170,901 Added 18.48%
1,095,805 $175 Million
Q1 2019

May 01, 2019

BUY
$115.84 - $160.31 $2.19 Million - $3.03 Million
18,882 Added 2.08%
924,904 $0
Q4 2018

Feb 14, 2019

BUY
$113.42 - $156.48 $27.1 Million - $37.4 Million
239,008 Added 35.83%
906,022 $111 Million
Q3 2018

Nov 13, 2018

BUY
$121.55 - $156.8 $5.55 Million - $7.16 Million
45,643 Added 7.35%
667,014 $99.9 Million
Q2 2018

Jul 17, 2018

BUY
$112.2 - $165.95 $4.45 Million - $6.58 Million
39,668 Added 6.82%
621,371 $85.8 Million
Q1 2018

May 10, 2018

BUY
$84.6 - $126.1 $42.4 Million - $63.2 Million
501,476 Added 625.07%
581,703 $67.3 Million
Q4 2017

Feb 13, 2018

BUY
$91.55 - $115.85 $1.06 Million - $1.34 Million
11,548 Added 16.81%
80,227 $7.55 Million
Q3 2017

Oct 20, 2017

BUY
$79.65 - $90.3 $5.47 Million - $6.2 Million
68,679
68,679 $6.2 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.11B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.